After all the excitement amongst the spruikers this past week that Brazil is where it’s at now the market has tanked in the US. The vote has nominally been delayed for 15 days
Brazil again delays vote on regulating cannabis cultivation and products registration, dealing further setback to open market says MJ Biz…
Brazilian health regulators unexpectedly postponed another vote on a groundbreaking proposal to regulate the cultivation and registration of cannabis-based medicines, delivering a further blow to efforts to open up fresh business opportunities in Latin America’s largest medical cannabis market.
The directory of the Brazilian Agência Nacional de Vigilância Sanitária – or National Sanitary Surveillance Agency (ANVISA) – was expected to vote Tuesday on two resolutions that for the first time would have established a regulatory framework on the domestic cultivation and registration of cannabis-based medicines without the need for finished clinical trials.
But two of ANVISA’s five directors – Fernando Mendes and Antonio Barra – asked to postpone the vote, effectively blocking any decision from happening.